This is the largest international investor forum for venture funded and small cap technology & biotech companies with over 60 companies presenting and 600 delegates participating in 2002.

The 2003 programme will focus on the global key issues and trends in the venture capital and private equity industries; with specialist panels providing expert discussions on Communications, Software, Security and Life Sciences.
Executive speakers include:

• Peter Gardner, Deputy Head of Communications Investments, 3i
• Sabine Kaiser, Investment Director Healthcare, 3i Deutschland
• Max Burger-Calderon, Partner, Apax Partners
• Thomas Puetter, CEO, Allianz Capital Partner
• Vijay K. Sondhi, Managing Director, Allianz Venture Partners
• Christoph Bellmer, Managing Director - Munich, b-business partners
• Katrin Horstmann, Managing Director, b-business partners
• Paul Wake, Editor, Biotechnology Investment Today
• Dr. Holger Frommann, Managing Director, BVK
• Michael Wand, Director, Carlyle Europe Venture Partners
• Soren Hein, Partner, Doughty Hanson Technology Ventures
• Timothy Draper, Managing Director, Draper Fisher Jurvetson
• Holger Heims, Managing Partner, DVC Deutsche Venture Capital
• Dr. Hendrik Brandis, Partner, Earlybird Venture Capital
• Martin Rigby, Managing Director, ET Capital
• Falk Strascheg, Founder and Managing Partner, Extorel
• Harald Ehren, Head of Inside Business, Financial Times Deutschland
• Michael Wrede, CEO, Future Capital AG
• Tom L. Smith, Global Executive Venture Development, IBM Venture Capital Group
• Ralf D. Schnell, Managing Director, Infineon Ventures
• Johann Weber, Sector Manager Wireless, Intel Capital Europe / Israel
• Maximilian Brönner, Partner, LGT Capital Partners
• Charlotte Crosswell, Head of Business Development – Europe & North America, London Stock Exchange
• Vojkan Brankovic, Manager – European Business Development, London Stock Exchange
• Rodney Brooks, Director, MIT Artificial Intelligence Laboratory
• Dr. Christian Zschocke, Managing Partner, Morgan Lewis & Bockius
• Adi Seffer, Partner, Morgan Lewis & Bockius
• Anthony Warnock-Smith, Partner, Morgan Lewis & Bockius
• Dr. Ansbert Gadicke, Founding General Partner, MPM Capital
• Dr. Denise Pollard-Knight, Head of Healthcare Private Equity, Nomura International plc
• Helmut Schön, Managing Director, Partech International
• Dr. Simon Waddington, Partner, PolyTechnos Venture-Partners
• Stephen Murphy, Managing Director, Head of Equity Private Placements Europe, Schroder
  Salomon Smith Barney
• Dr. Martin Haemmig, Adj. Professor and Researcher for Venture Capital, SECA
• Dr. Dietrich Ulmer, CEO & President, Siemens Mobile Acceleration (smac)
• Bjoern Eske Christensen, President & CEO, Siemens Venture Capital
• Tim Minshall, Board of Directors, St. John's Innovation Centre Ltd
• Frances Bornstein, Vice President, SWX Swiss Exchange
• Kurt Mueller, Partner, Target Partners
• Michael Boshammer, Invetment Director , T-Mobile Venture
• Friedrich Bornikoel, Managing Partner, Techno Venture Management
• Peter L. Levin, General Partner, Techno Venture Management Boston
• Dr. Christian Waldvogel, Partner, Viventures Partners
• Melchior Stahl, Managing Director, Warburg Pincus – Munich
• Ivy Lindstrom Fredericks, Managing Director of Corporate Finance, Westminster Securities

In addition, there will be a special feature on New Technologies, with a focus on nanotechnology, alternative forms of energy and artificial intelligence. Sponsors presently include b-business partners, DVC Deutsche Venture Capital, Future Capital, IBM Corporation, Infineon Ventures, Kirchhoff Consult AG, London Stock Exchange, Morgan Lewis, Siemens Mobile Acceleration, Techno Venture Management, Westminster Securities, and there will be extensive media coverage from Bloomberg and other regular media partners - Financial Times Deutschland, Finance, Going Public etc. There is also continued support from regional venture associations.

Over 45 start-up to pre-IPO companies will present in sector workshops representing:
Communications: Wireless, Optical, Bandwidth Usage, Services, Networks
Software: Security
New Technologies: Nanotech, Renewable Energy, Artificial Intelligence, New Materials
Life Sciences: Biotech, Healthcare, Pharmaceuticals, Medical Devices.